1 Study Coverage 1.1 Direct Oral Anticoagulant Product Introduction 1.2 Global Direct Oral Anticoagulant Outlook 2017 VS 2022 VS 2028 1.2.1 Global Direct Oral Anticoagulant Sales in US$ Million for the Year 2017-2028 1.2.2 Global Direct Oral Anticoagulant Sales in Volume for the Year 2017-2028 1.3 United States Direct Oral Anticoagulant Outlook 2017 VS 2022 VS 2028 1.3.1 United States Direct Oral Anticoagulant Sales in US$ Million for the Year 2017-2028 1.3.2 United States Direct Oral Anticoagulant Sales in Volume for the Year 2017-2028 1.4 Direct Oral Anticoagulant Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Direct Oral Anticoagulant in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Direct Oral Anticoagulant Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Direct Oral Anticoagulant Market Dynamics 1.5.1 Direct Oral Anticoagulant Industry Trends 1.5.2 Direct Oral Anticoagulant Market Drivers 1.5.3 Direct Oral Anticoagulant Market Challenges 1.5.4 Direct Oral Anticoagulant Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Direct Oral Anticoagulant Market Segment by Type 2.1.1 Apixaban 2.1.2 Dabigatran 2.1.3 Rivaroxaban 2.1.4 Edoxaban 2.2 Global Direct Oral Anticoagulant Market Size by Type 2.2.1 Global Direct Oral Anticoagulant Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Direct Oral Anticoagulant Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Direct Oral Anticoagulant Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Direct Oral Anticoagulant Market Size by Type 2.3.1 United States Direct Oral Anticoagulant Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Direct Oral Anticoagulant Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Direct Oral Anticoagulant Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Direct Oral Anticoagulant Market Segment by Application 3.1.1 Hospitals Pharmacies 3.1.2 Drug Stores 3.1.3 Online Pharmacies 3.2 Global Direct Oral Anticoagulant Market Size by Application 3.2.1 Global Direct Oral Anticoagulant Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Direct Oral Anticoagulant Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Direct Oral Anticoagulant Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Direct Oral Anticoagulant Market Size by Application 3.3.1 United States Direct Oral Anticoagulant Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Direct Oral Anticoagulant Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Direct Oral Anticoagulant Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Direct Oral Anticoagulant Competitor Landscape by Company 4.1 Global Direct Oral Anticoagulant Market Size by Company 4.1.1 Top Global Direct Oral Anticoagulant Manufacturers Ranked by Revenue (2021) 4.1.2 Global Direct Oral Anticoagulant Revenue by Manufacturer (2017-2022) 4.1.3 Global Direct Oral Anticoagulant Sales by Manufacturer (2017-2022) 4.1.4 Global Direct Oral Anticoagulant Price by Manufacturer (2017-2022) 4.2 Global Direct Oral Anticoagulant Concentration Ratio (CR) 4.2.1 Direct Oral Anticoagulant Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Direct Oral Anticoagulant in 2021 4.2.3 Global Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Direct Oral Anticoagulant Manufacturing Base Distribution, Product Type 4.3.1 Global Direct Oral Anticoagulant Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Direct Oral Anticoagulant Product Type 4.3.3 Date of International Manufacturers Enter into Direct Oral Anticoagulant Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Direct Oral Anticoagulant Market Size by Company 4.5.1 Top Direct Oral Anticoagulant Players in United States, Ranked by Revenue (2021) 4.5.2 United States Direct Oral Anticoagulant Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Direct Oral Anticoagulant Sales by Players (2020, 2021 & 2022) 5 Global Direct Oral Anticoagulant Market Size by Region 5.1 Global Direct Oral Anticoagulant Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Direct Oral Anticoagulant Market Size in Volume by Region (2017-2028) 5.2.1 Global Direct Oral Anticoagulant Sales in Volume by Region: 2017-2022 5.2.2 Global Direct Oral Anticoagulant Sales in Volume Forecast by Region (2023-2028) 5.3 Global Direct Oral Anticoagulant Market Size in Value by Region (2017-2028) 5.3.1 Global Direct Oral Anticoagulant Sales in Value by Region: 2017-2022 5.3.2 Global Direct Oral Anticoagulant Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Direct Oral Anticoagulant Market Size YoY Growth 2017-2028 6.1.2 North America Direct Oral Anticoagulant Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Direct Oral Anticoagulant Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Direct Oral Anticoagulant Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Direct Oral Anticoagulant Market Size YoY Growth 2017-2028 6.3.2 Europe Direct Oral Anticoagulant Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Direct Oral Anticoagulant Market Size YoY Growth 2017-2028 6.4.2 Latin America Direct Oral Anticoagulant Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Direct Oral Anticoagulant Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Direct Oral Anticoagulant Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Bristol-Meyers Squibb Co 7.1.1 Bristol-Meyers Squibb Co Corporation Information 7.1.2 Bristol-Meyers Squibb Co Description and Business Overview 7.1.3 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Products Offered 7.1.5 Bristol-Meyers Squibb Co Recent Development 7.2 Pfizer Inc. 7.2.1 Pfizer Inc. Corporation Information 7.2.2 Pfizer Inc. Description and Business Overview 7.2.3 Pfizer Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Pfizer Inc. Direct Oral Anticoagulant Products Offered 7.2.5 Pfizer Inc. Recent Development 7.3 Boehringer Ingelheim Pharmaceuticals, Inc 7.3.1 Boehringer Ingelheim Pharmaceuticals, Inc Corporation Information 7.3.2 Boehringer Ingelheim Pharmaceuticals, Inc Description and Business Overview 7.3.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Products Offered 7.3.5 Boehringer Ingelheim Pharmaceuticals, Inc Recent Development 7.4 Janssen Pharmaceuticals, Inc. 7.4.1 Janssen Pharmaceuticals, Inc. Corporation Information 7.4.2 Janssen Pharmaceuticals, Inc. Description and Business Overview 7.4.3 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Products Offered 7.4.5 Janssen Pharmaceuticals, Inc. Recent Development 7.5 Bayer AG 7.5.1 Bayer AG Corporation Information 7.5.2 Bayer AG Description and Business Overview 7.5.3 Bayer AG Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Bayer AG Direct Oral Anticoagulant Products Offered 7.5.5 Bayer AG Recent Development 7.6 Teva Pharmaceutical Industries Ltd 7.6.1 Teva Pharmaceutical Industries Ltd Corporation Information 7.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview 7.6.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Products Offered 7.6.5 Teva Pharmaceutical Industries Ltd Recent Development 7.7 Pab Organics Private Limited 7.7.1 Pab Organics Private Limited Corporation Information 7.7.2 Pab Organics Private Limited Description and Business Overview 7.7.3 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Pab Organics Private Limited Direct Oral Anticoagulant Products Offered 7.7.5 Pab Organics Private Limited Recent Development 7.8 Daiichi Sankyo Company, Limited 7.8.1 Daiichi Sankyo Company, Limited Corporation Information 7.8.2 Daiichi Sankyo Company, Limited Description and Business Overview 7.8.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Products Offered 7.8.5 Daiichi Sankyo Company, Limited Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Direct Oral Anticoagulant Industry Chain Analysis 8.2 Direct Oral Anticoagulant Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Direct Oral Anticoagulant Distributors 8.3 Direct Oral Anticoagulant Production Mode & Process 8.4 Direct Oral Anticoagulant Sales and Marketing 8.4.1 Direct Oral Anticoagulant Sales Channels 8.4.2 Direct Oral Anticoagulant Distributors 8.5 Direct Oral Anticoagulant Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Direct Oral Anticoagulant CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Direct Oral Anticoagulant Market Trends Table 3. Direct Oral Anticoagulant Market Drivers Table 4. Direct Oral Anticoagulant Market Challenges Table 5. Direct Oral Anticoagulant Market Restraints Table 6. Global Direct Oral Anticoagulant Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Direct Oral Anticoagulant Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Direct Oral Anticoagulant Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Direct Oral Anticoagulant Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Direct Oral Anticoagulant Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Direct Oral Anticoagulant Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Direct Oral Anticoagulant Revenue Share by Manufacturer, 2017-2022 Table 13. Global Direct Oral Anticoagulant Sales by Manufacturer, (MT), 2017-2022 Table 14. Global Direct Oral Anticoagulant Sales Share by Manufacturer, 2017-2022 Table 15. Global Direct Oral Anticoagulant Price by Manufacturer (2017-2022) & (USD/Kg) Table 16. Global Direct Oral Anticoagulant Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Direct Oral Anticoagulant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct Oral Anticoagulant as of 2021) Table 18. Top Players of Direct Oral Anticoagulant in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Direct Oral Anticoagulant Product Type Table 20. Date of International Manufacturers Enter into Direct Oral Anticoagulant Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Direct Oral Anticoagulant Players in United States Market, Ranking by Revenue (2021) Table 23. United States Direct Oral Anticoagulant Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Direct Oral Anticoagulant Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Direct Oral Anticoagulant Sales by Players, (MT), 2020, 2021 & 2022 Table 26. United States Direct Oral Anticoagulant Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Direct Oral Anticoagulant Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Direct Oral Anticoagulant Sales in Volume by Region (2017-2022) & (MT) Table 29. Global Direct Oral Anticoagulant Sales in Volume Forecast by Region (2023-2028) & (MT) Table 30. Global Direct Oral Anticoagulant Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Direct Oral Anticoagulant Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Direct Oral Anticoagulant Sales in Volume by Country (2017-2028) & (MT) Table 33. North America Direct Oral Anticoagulant Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Direct Oral Anticoagulant Sales in Volume by Region (2017-2028) & (MT) Table 35. Asia Pacific Direct Oral Anticoagulant Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Direct Oral Anticoagulant Sales in Volume by Country (2017-2028) & (MT) Table 37. Europe Direct Oral Anticoagulant Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Direct Oral Anticoagulant Sales in Volume by Country (2017-2028) & (MT) Table 39. Latin Americaa Direct Oral Anticoagulant Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Direct Oral Anticoagulant Sales in Volume by Country (2017-2028) & (MT) Table 41. Middle East and Africa Direct Oral Anticoagulant Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Bristol-Meyers Squibb Co Corporation Information Table 43. Bristol-Meyers Squibb Co Description and Business Overview Table 44. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 45. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product Table 46. Bristol-Meyers Squibb Co Recent Development Table 47. Pfizer Inc. Corporation Information Table 48. Pfizer Inc. Description and Business Overview Table 49. Pfizer Inc. Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 50. Pfizer Inc. Product Table 51. Pfizer Inc. Recent Development Table 52. Boehringer Ingelheim Pharmaceuticals, Inc Corporation Information Table 53. Boehringer Ingelheim Pharmaceuticals, Inc Description and Business Overview Table 54. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 55. Boehringer Ingelheim Pharmaceuticals, Inc Product Table 56. Boehringer Ingelheim Pharmaceuticals, Inc Recent Development Table 57. Janssen Pharmaceuticals, Inc. Corporation Information Table 58. Janssen Pharmaceuticals, Inc. Description and Business Overview Table 59. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 60. Janssen Pharmaceuticals, Inc. Product Table 61. Janssen Pharmaceuticals, Inc. Recent Development Table 62. Bayer AG Corporation Information Table 63. Bayer AG Description and Business Overview Table 64. Bayer AG Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 65. Bayer AG Product Table 66. Bayer AG Recent Development Table 67. Teva Pharmaceutical Industries Ltd Corporation Information Table 68. Teva Pharmaceutical Industries Ltd Description and Business Overview Table 69. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 70. Teva Pharmaceutical Industries Ltd Product Table 71. Teva Pharmaceutical Industries Ltd Recent Development Table 72. Pab Organics Private Limited Corporation Information Table 73. Pab Organics Private Limited Description and Business Overview Table 74. Pab Organics Private Limited Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 75. Pab Organics Private Limited Product Table 76. Pab Organics Private Limited Recent Development Table 77. Daiichi Sankyo Company, Limited Corporation Information Table 78. Daiichi Sankyo Company, Limited Description and Business Overview Table 79. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 80. Daiichi Sankyo Company, Limited Product Table 81. Daiichi Sankyo Company, Limited Recent Development Table 82. Key Raw Materials Lists Table 83. Raw Materials Key Suppliers Lists Table 84. Direct Oral Anticoagulant Customers List Table 85. Direct Oral Anticoagulant Distributors List Table 86. Research Programs/Design for This Report Table 87. Key Data Information from Secondary Sources Table 88. Key Data Information from Primary Sources List of Figures Figure 1. Direct Oral Anticoagulant Product Picture Figure 2. Global Direct Oral Anticoagulant Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Direct Oral Anticoagulant Market Size 2017-2028 (US$ Million) Figure 4. Global Direct Oral Anticoagulant Sales 2017-2028 (MT) Figure 5. United States Direct Oral Anticoagulant Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Direct Oral Anticoagulant Market Size 2017-2028 (US$ Million) Figure 7. United States Direct Oral Anticoagulant Sales 2017-2028 (MT) Figure 8. United States Direct Oral Anticoagulant Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Direct Oral Anticoagulant Market Share in Global, in Volume (MT) 2017-2028 Figure 10. Direct Oral Anticoagulant Report Years Considered Figure 11. Product Picture of Apixaban Figure 12. Product Picture of Dabigatran Figure 13. Product Picture of Rivaroxaban Figure 14. Product Picture of Edoxaban Figure 15. Global Direct Oral Anticoagulant Market Share by Type in 2022 & 2028 Figure 16. Global Direct Oral Anticoagulant Sales in Value by Type (2017-2028) & (US$ Million) Figure 17. Global Direct Oral Anticoagulant Sales Market Share in Value by Type (2017-2028) Figure 18. Global Direct Oral Anticoagulant Sales by Type (2017-2028) & (MT) Figure 19. Global Direct Oral Anticoagulant Sales Market Share in Volume by Type (2017-2028) Figure 20. Global Direct Oral Anticoagulant Price by Type (2017-2028) & (USD/Kg) Figure 21. United States Direct Oral Anticoagulant Market Share by Type in 2022 & 2028 Figure 22. United States Direct Oral Anticoagulant Sales in Value by Type (2017-2028) & (US$ Million) Figure 23. United States Direct Oral Anticoagulant Sales Market Share in Value by Type (2017-2028) Figure 24. United States Direct Oral Anticoagulant Sales by Type (2017-2028) & (MT) Figure 25. United States Direct Oral Anticoagulant Sales Market Share in Volume by Type (2017-2028) Figure 26. United States Direct Oral Anticoagulant Price by Type (2017-2028) & (USD/Kg) Figure 27. Product Picture of Hospitals Pharmacies Figure 28. Product Picture of Drug Stores Figure 29. Product Picture of Online Pharmacies Figure 30. Global Direct Oral Anticoagulant Market Share by Application in 2022 & 2028 Figure 31. Global Direct Oral Anticoagulant Sales in Value by Application (2017-2028) & (US$ Million) Figure 32. Global Direct Oral Anticoagulant Sales Market Share in Value by Application (2017-2028) Figure 33. Global Direct Oral Anticoagulant Sales by Application (2017-2028) & (MT) Figure 34. Global Direct Oral Anticoagulant Sales Market Share in Volume by Application (2017-2028) Figure 35. Global Direct Oral Anticoagulant Price by Application (2017-2028) & (USD/Kg) Figure 36. United States Direct Oral Anticoagulant Market Share by Application in 2022 & 2028 Figure 37. United States Direct Oral Anticoagulant Sales in Value by Application (2017-2028) & (US$ Million) Figure 38. United States Direct Oral Anticoagulant Sales Market Share in Value by Application (2017-2028) Figure 39. United States Direct Oral Anticoagulant Sales by Application (2017-2028) & (MT) Figure 40. United States Direct Oral Anticoagulant Sales Market Share in Volume by Application (2017-2028) Figure 41. United States Direct Oral Anticoagulant Price by Application (2017-2028) & (USD/Kg) Figure 42. North America Direct Oral Anticoagulant Sales in Volume Growth Rate 2017-2028 (MT) Figure 43. North America Direct Oral Anticoagulant Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 44. U.S. Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Canada Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 46. Europe Direct Oral Anticoagulant Sales in Volume Growth Rate 2017-2028 (MT) Figure 47. Europe Direct Oral Anticoagulant Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 48. Germany Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. France Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. U.K. Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Italy Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Russia Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Asia-Pacific Direct Oral Anticoagulant Sales in Volume Growth Rate 2017-2028 (MT) Figure 54. Asia-Pacific Direct Oral Anticoagulant Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 55. China Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Japan Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. South Korea Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. India Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Australia Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Taiwan Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Indonesia Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Thailand Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Malaysia Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Philippines Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Latin America Direct Oral Anticoagulant Sales in Volume Growth Rate 2017-2028 (MT) Figure 66. Latin America Direct Oral Anticoagulant Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 67. Mexico Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Brazil Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Argentina Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Middle East & Africa Direct Oral Anticoagulant Sales in Volume Growth Rate 2017-2028 (MT) Figure 71. Middle East & Africa Direct Oral Anticoagulant Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 72. Turkey Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Saudi Arabia Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. U.A.E Direct Oral Anticoagulant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 75. Direct Oral Anticoagulant Value Chain Figure 76. Direct Oral Anticoagulant Production Process Figure 77. Channels of Distribution Figure 78. Distributors Profiles Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed

Bristol-Meyers Squibb Co Pfizer Inc. Boehringer Ingelheim Pharmaceuticals, Inc Janssen Pharmaceuticals, Inc. Bayer AG Teva Pharmaceutical Industries Ltd Pab Organics Private Limited Daiichi Sankyo Company, Limited